The Company has operating leases for corporate and medical offices. These leases have remaining lease terms ranging from 7 months to 20 years, some of which may include options to extend the leases for up to ten years, and some of which may include options to terminate the leases within one year. These leases consist of payments that are fixed or variable. Variable lease payments are based on an index or a rate such as the Consumer Price Index.

Operating lease costs for the three months ended September 30, 2025 and 2024 were $4.7 million and $3.2 million, respectively. Operating cash flows from operating leases for the three months ended September 30, 2025 and 2024 were $3.9 million and $3.1 million, respectively. Operating lease costs for the nine months ended September 30, 2025 and 2024 were $11.9 million and $9.4 million, respectively. Operating cash flows from operating leases for the nine months ended September 30, 2025 and 2024 were $10.1 million and $8.7 million, respectively.

Leases with an initial term of 12 months or less are not recorded on the condensed consolidated balance sheets.